Nightingale Health

Reaching for the unreasonable


Nightingale aims to transform healthcare for chronic diseases from one of sick care to one of prediction and prevention.


Nightingale Health Ltd.

Nightingale Health is a Finnish biomedical company aiming to solve the world’s biggest health problem with their proprietary blood analysis platform. At the core of the technology is the improved risk prediction of chronic diseases, such as diabetes and cardiovascular diseases.

Nightingale is built upon an unrivalled scientific foundation, and comprises of an interdisciplinary team of experts in computational medicine, healthcare IT and business. With headquarters and laboratory facilities in Finland and two franchising laboratories in the UK, Nightingale serves academic research customers around the world. The next major milestone for the company is bringing their blood analysis solution part of routine healthcare globally.

Entrepreneurs

Teemu SunaTeemu SunaChief Executive Officer
Satu SaksmanSatu SaksmanChief Operating Officer
Antti KangasAntti KangasChief Technology Officer
Antti KangasPeter WürtzScientific Director
Pasi SoininenPasi SoininenLaboratory Director

Board of directors

Teemu SunaChairman of board
Antti KangasMember of Board
Olli KarhiMember of Board
Juha PöysäMember of Board
Harri RehnbergMember of Board

Milestones

Member of

MIT SOLVE
Startup Health

Contact

Headquarters
Nightingale Health Ltd.Teknobulevardi 3-5
01530 Vantaa
Finland
Sales and partnerships
Teemu SunaChief Executive OfficerSatu SaksmanChief Operating Officer
Press
Kristiina TolvanenChief Communications Officer